199 related articles for article (PubMed ID: 33678581)
1. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.
Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q
Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluating early recurrence in resectable pancreatic ductal adenocarcinoma by using CT radiomics.
Wang G; Lei W; Duan S; Cao A; Shi H
Abdom Radiol (NY); 2024 Feb; 49(2):484-491. PubMed ID: 37955726
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
4. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
5. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients.
Wang F; Zhao Y; Xu J; Shao S; Yu D
Front Oncol; 2022; 12():1037672. PubMed ID: 36518321
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
[TBL] [Abstract][Full Text] [Related]
8. Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.
Liang L; Ding Y; Yu Y; Liu K; Rao S; Ge Y; Zeng M
BMC Med Imaging; 2021 Apr; 21(1):75. PubMed ID: 33902469
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
[No Abstract] [Full Text] [Related]
10. Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.
Li K; Yao Q; Xiao J; Li M; Yang J; Hou W; Du M; Chen K; Qu Y; Li L; Li J; Wang X; Luo H; Yang J; Zhang Z; Chen W
Cancer Imaging; 2020 Jan; 20(1):12. PubMed ID: 32000852
[TBL] [Abstract][Full Text] [Related]
11. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
12. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
[TBL] [Abstract][Full Text] [Related]
15. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients.
Wang K; Karalis JD; Elamir A; Bifolco A; Wachsmann M; Capretti G; Spaggiari P; Enrico S; Balasubramanian K; Fatimah N; Pontecorvi G; Nebbia M; Yopp A; Kaza R; Pedrosa I; Zeh H; Polanco P; Zerbi A; Wang J; Aguilera T; Ligorio M
Ann Surg Oncol; 2024 Apr; 31(4):2608-2620. PubMed ID: 38151623
[TBL] [Abstract][Full Text] [Related]
16. Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection.
van der Kroft G; Wee L; Rensen SS; Brecheisen R; van Dijk DPJ; Eickhoff R; Roeth AA; Ulmer FT; Dekker A; Neumann UP; Olde Damink SWM
Front Oncol; 2023; 13():1062937. PubMed ID: 37637046
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
18. Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.
Chang N; Cui L; Luo Y; Chang Z; Yu B; Liu Z
Quant Imaging Med Surg; 2020 Mar; 10(3):692-702. PubMed ID: 32269929
[TBL] [Abstract][Full Text] [Related]
19. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]